Angiotensin-Converting Enzyme Inhibitors but Not Angiotensin II AT 1 Receptor Antagonists Affect Erythropoiesis in Patients with Anemia of End-Stage Renal Disease

Publisher： Karger

E-ISSN： 2235-3186|81|1|106-108

ISSN： 1660-8151

Source： Nephron, Vol.81, Iss.1, 1999-01, pp. : 106-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Polymorphism of the Angiotensin-Converting Enzyme Gene in End-Stage Renal Failure Patients

By  

Nephron, Vol. 85, Iss. 1, 2000-04 ,pp. : 54-59

Karger

Access to resources Recommend Favorite

Effects of an Angiotensin II Receptor Antagonist and Angiotensin-Converting Enzyme Inhibitors on Burst Forming Units-Erythroid in Chronic Hemodialysis Patients

By  

American Journal of Nephrology, Vol. 23, Iss. 5, 2003-09 ,pp. : 287-293

Karger

Access to resources Recommend Favorite

Renoprotective Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Diabetic Patients with Proteinuria

By  

Kidney and Blood Pressure Research, Vol. 42, Iss. 2, 2017-06 ,pp. : 358-368

Karger

Access to resources Recommend Favorite

Relationship between Polymorphism in the Angiotensinogen, Angiotensin-Converting Enzyme or Angiotensin II Receptor and Renal Progression in Japanese NIDDM Patients

By  

Nephron, Vol. 82, Iss. 2, 1999-06 ,pp. : 139-144

Karger

Access to resources Recommend Favorite

Angiotensin II Type 1 Receptor Antagonist, Losartan, Causes Regression of Left Ventricular Hypertrophy in End-Stage Renal Disease

By  

Nephron, Vol. 90, Iss. 3, 2002-02 ,pp. : 256-261

Karger

Access to resources Recommend Favorite